$BVS
Bioventus Inc.

2021 Q4 Form 10-Q Financial Statement

#000162828021022681 Filed on November 10, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2020 Q3
Revenue $108.9M $85.91M
YoY Change 10.45% 4.46%
Cost Of Revenue $29.82M $23.44M
YoY Change 18.71% 8.14%
Gross Profit $79.07M $62.46M
YoY Change 7.62% 3.14%
Gross Profit Margin 72.61% 72.71%
Selling, General & Admin $69.64M $50.30M
YoY Change 12.84% 11.47%
% of Gross Profit 88.07% 80.52%
Research & Development $6.153M $3.569M
YoY Change 112.91% 25.23%
% of Gross Profit 7.78% 5.71%
Depreciation & Amortization $8.522M $7.280M
YoY Change 24.41% 0.28%
% of Gross Profit 10.78% 11.65%
Operating Expenses $75.79M $53.86M
YoY Change 13.56% 7.81%
Operating Profit -$1.047M $6.933M
YoY Change -115.56% -34.59%
Interest Expense -$1.347M -$1.880M
YoY Change -48.19% -59.57%
% of Operating Profit -27.12%
Other Income/Expense, Net -$2.104M $1.405M
YoY Change 1402.86% 4583.33%
Pretax Income -$3.151M $8.338M
YoY Change -200.35% 39.43%
Income Tax -$882.0K $373.0K
% Of Pretax Income 4.47%
Net Earnings -$1.071M $8.457M
YoY Change -138.53% 49.95%
Net Earnings / Revenue -0.98% 9.84%
Basic Earnings Per Share -$0.03
Diluted Earnings Per Share -$0.03 $152.1K
COMMON SHARES
Basic Shares Outstanding 41.84M shares
Diluted Shares Outstanding 41.84M shares

Balance Sheet

Concept 2021 Q4 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $80.92M $72.50M
YoY Change -6.78%
Cash & Equivalents $43.93M $72.48M
Short-Term Investments
Other Short-Term Assets $23.15M $5.000M
YoY Change 208.72%
Inventory $61.69M $34.70M
Prepaid Expenses
Receivables $125.0M $80.90M
Other Receivables $0.00 $0.00
Total Short-Term Assets $263.1M $193.1M
YoY Change 24.23%
LONG-TERM ASSETS
Property, Plant & Equipment $22.99M $19.80M
YoY Change 234.13%
Goodwill $147.6M
YoY Change 196.43%
Intangibles $695.2M
YoY Change 262.74%
Long-Term Investments $29.32M $19.90M
YoY Change 51.12%
Other Assets $50.48M
YoY Change
Total Long-Term Assets $962.8M $286.2M
YoY Change 240.59%
TOTAL ASSETS
Total Short-Term Assets $263.1M $193.1M
Total Long-Term Assets $962.8M $286.2M
Total Assets $1.226B $479.3M
YoY Change 147.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $16.92M $8.800M
YoY Change 282.52%
Accrued Expenses $131.5M $79.90M
YoY Change 49.08%
Deferred Revenue $2.399M
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $18.04M $16.30M
YoY Change 20.25%
Total Short-Term Liabilities $180.9M $111.7M
YoY Change 47.53%
LONG-TERM LIABILITIES
Long-Term Debt $339.6M $177.0M
YoY Change 95.9%
Other Long-Term Liabilities $21.72M $41.70M
YoY Change -0.02%
Total Long-Term Liabilities $361.4M $218.7M
YoY Change 85.22%
TOTAL LIABILITIES
Total Short-Term Liabilities $180.9M $111.7M
Total Long-Term Liabilities $361.4M $218.7M
Total Liabilities $692.1M $336.1M
YoY Change 97.56%
SHAREHOLDERS EQUITY
Retained Earnings -$6.602M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $458.9M $143.2M
YoY Change
Total Liabilities & Shareholders Equity $1.226B $479.3M
YoY Change 147.92%

Cashflow Statement

Concept 2021 Q4 2020 Q3
OPERATING ACTIVITIES
Net Income -$1.071M $8.457M
YoY Change -138.53% 49.95%
Depreciation, Depletion And Amortization $8.522M $7.280M
YoY Change 24.41% 0.28%
Cash From Operating Activities $10.59M $20.84M
YoY Change -58.4% 77.97%
INVESTING ACTIVITIES
Capital Expenditures -$1.926M -$1.280M
YoY Change 9.43% 166.67%
Acquisitions
YoY Change
Other Investing Activities -$11.26M -$16.48M
YoY Change -22620.0% -3932.56%
Cash From Investing Activities -$13.19M -$17.76M
YoY Change 671.11% 35420.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -4.346M -57.12M
YoY Change -56.01% 10677.36%
NET CHANGE
Cash From Operating Activities 10.59M 20.84M
Cash From Investing Activities -13.19M -17.76M
Cash From Financing Activities -4.346M -57.12M
Net Change In Cash -6.945M -54.04M
YoY Change -150.11% -585.53%
FREE CASH FLOW
Cash From Operating Activities $10.59M $20.84M
Capital Expenditures -$1.926M -$1.280M
Free Cash Flow $12.51M $22.12M
YoY Change -54.01% 81.46%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
BIOVENTUS INC.
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-10-02
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001665988
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Type
DocumentType
10-Q
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37844
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-0980861
dei Entity Address Address Line1
EntityAddressAddressLine1
4721 Emperor Boulevard
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
dei Entity Address City Or Town
EntityAddressCityOrTown
Durham
dei Entity Address State Or Province
EntityAddressStateOrProvince
NC
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
27703
dei City Area Code
CityAreaCode
919
dei Local Phone Number
LocalPhoneNumber
474-6700
dei Security12b Title
Security12bTitle
Class A Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
BVS
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
108890000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
85908000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
300484000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
222570000 USD
CY2021Q4 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
6637000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
5477000 USD
us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
17491000 USD
us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
16076000 USD
CY2021Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
29821000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
23444000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
85546000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
62521000 USD
CY2021Q4 us-gaap Gross Profit
GrossProfit
79069000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
62464000 USD
us-gaap Gross Profit
GrossProfit
214938000 USD
us-gaap Gross Profit
GrossProfit
160049000 USD
CY2021Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
69636000 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
50295000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
173372000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
131104000 USD
CY2021Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6153000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3569000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11936000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8311000 USD
CY2021Q4 us-gaap Restructuring Charges
RestructuringCharges
1798000 USD
CY2020Q3 us-gaap Restructuring Charges
RestructuringCharges
0 USD
us-gaap Restructuring Charges
RestructuringCharges
1798000 USD
us-gaap Restructuring Charges
RestructuringCharges
0 USD
CY2021Q4 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
651000 USD
CY2020Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1292000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
CY2021Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1878000 USD
CY2020Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1667000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5655000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5305000 USD
CY2021Q4 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2020Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
5674000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-1047000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
6933000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
15211000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
15329000 USD
CY2021Q4 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1347000 USD
CY2020Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1880000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-152000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-7095000 USD
CY2021Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-757000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3285000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2821000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4539000 USD
CY2021Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2104000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1405000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2973000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2556000 USD
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3151000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8338000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
12238000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
12773000 USD
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-882000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
373000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
759000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
302000 USD
CY2021Q4 us-gaap Profit Loss
ProfitLoss
-2269000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
7965000 USD
us-gaap Profit Loss
ProfitLoss
11479000 USD
us-gaap Profit Loss
ProfitLoss
12471000 USD
CY2021Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1198000 USD
CY2020Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-492000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-8260000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1164000 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-1071000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
8457000 USD
us-gaap Net Income Loss
NetIncomeLoss
19739000 USD
us-gaap Net Income Loss
NetIncomeLoss
13635000 USD
CY2021Q4 us-gaap Profit Loss
ProfitLoss
-2269000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
7965000 USD
us-gaap Profit Loss
ProfitLoss
11479000 USD
us-gaap Profit Loss
ProfitLoss
12471000 USD
CY2021Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-366000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
943000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1225000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
687000 USD
CY2021Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-2635000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
8908000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
10254000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
13158000 USD
CY2021Q4 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1300000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-492000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-8182000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1164000 USD
CY2021Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1335000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
9400000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
18436000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
14322000 USD
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41837581 shares
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41837581 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41816706 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41816706 shares
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
80917000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
86839000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
105442000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
88283000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
36565000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
29120000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23154000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7552000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
246078000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
211794000 USD
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
50000000 USD
CY2020Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
0 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10297000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6879000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
52885000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
49800000 USD
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
248794000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
191650000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16938000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14961000 USD
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
481000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
0 USD
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
29317000 USD
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
19382000 USD
CY2021Q4 us-gaap Assets
Assets
654790000 USD
CY2020Q4 us-gaap Assets
Assets
494466000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10897000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4422000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
107554000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
88187000 USD
CY2021Q4 us-gaap Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
10875000 USD
CY2020Q4 us-gaap Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
11054000 USD
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
15000000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
15000000 USD
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
13386000 USD
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
0 USD
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2993000 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3926000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
160705000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
122589000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
162437000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
173378000 USD
CY2021Q4 us-gaap Deferred Compensation Sharebased Arrangements Liability Classified Noncurrent
DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent
0 USD
CY2020Q4 us-gaap Deferred Compensation Sharebased Arrangements Liability Classified Noncurrent
DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent
29249000 USD
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
47687000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3362000 USD
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
30906000 USD
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
22558000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
21728000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
424293000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
350306000 USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Members Equity
MembersEquity
144160000 USD
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
158480000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6238000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
204000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
152503000 USD
CY2020Q4 us-gaap Members Equity
MembersEquity
144160000 USD
CY2021Q4 us-gaap Minority Interest
MinorityInterest
77994000 USD
CY2020Q4 us-gaap Members Equity Attributable To Noncontrolling Interest
MembersEquityAttributableToNoncontrollingInterest
0 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
230497000 USD
CY2020Q4 us-gaap Limited Liability Company Llc Members Equity Including Portion Attributable To Noncontrolling Interest
LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest
144160000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
654790000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
494466000 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
219364000 USD
CY2021Q4 us-gaap Stockholders Equity Change In Reporting Entity
StockholdersEquityChangeInReportingEntity
7437000 USD
CY2021Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
417000 USD
CY2021Q4 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
24000 USD
CY2021Q4 us-gaap Profit Loss
ProfitLoss
-2269000 USD
CY2021Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5938000 USD
CY2021Q4 bvs Other Comprehensive Income Loss Cumulative Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossCumulativeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-366000 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
230497000 USD
CY2020Q4 us-gaap Members Equity
MembersEquity
144160000 USD
bvs Members Equity Increase From Refunds From Members
MembersEquityIncreaseFromRefundsFromMembers
123000 USD
bvs Members Equity Decrease From Equity Forfeitures
MembersEquityDecreaseFromEquityForfeitures
39000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
25977000 USD
CY2021Q1 bvs Other Comprehensive Income Loss Cumulative Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossCumulativeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1507000 USD
us-gaap Stockholders Equity Change In Reporting Entity
StockholdersEquityChangeInReportingEntity
-48487000 USD
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
215000 USD
us-gaap Profit Loss
ProfitLoss
-14498000 USD
bvs Noncontrolling Interest Increase From Deconsolidation Of Variable Interest Entity
NoncontrollingInterestIncreaseFromDeconsolidationOfVariableInterestEntity
3746000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13774000 USD
bvs Other Comprehensive Income Loss Cumulative Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossCumulativeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
282000 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
230497000 USD
us-gaap Profit Loss
ProfitLoss
11479000 USD
us-gaap Profit Loss
ProfitLoss
12471000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
23185000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
21789000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-138000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1089000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
13735000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
0 USD
bvs Profits Interest Plan Liability Classified And Other Equity Awards Compensation
ProfitsInterestPlanLiabilityClassifiedAndOtherEquityAwardsCompensation
24356000 USD
bvs Profits Interest Plan Liability Classified And Other Equity Awards Compensation
ProfitsInterestPlanLiabilityClassifiedAndOtherEquityAwardsCompensation
-619000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1292000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1391000 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1980000 USD
bvs Change In Fair Value Of Equity Participation Rights
ChangeInFairValueOfEquityParticipationRights
2774000 USD
bvs Change In Fair Value Of Equity Participation Rights
ChangeInFairValueOfEquityParticipationRights
788000 USD
bvs Impairment Of Variable Interest Entity And Related Assets
ImpairmentOfVariableInterestEntityAndRelatedAssets
7043000 USD
bvs Impairment Of Variable Interest Entity And Related Assets
ImpairmentOfVariableInterestEntityAndRelatedAssets
0 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-72000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-266000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
13149000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3361000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1496000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7004000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
7247000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
11568000 USD
us-gaap Increase Decrease In Other Current Assets And Liabilities Net
IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet
13723000 USD
us-gaap Increase Decrease In Other Current Assets And Liabilities Net
IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet
-1933000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
9874000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
46752000 USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
0 USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-400000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
9874000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
46352000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
46790000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
11124000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
16630000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4568000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2331000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-62482000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-18961000 USD
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
0 USD
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
172000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-62482000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18789000 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
107777000 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
747000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
0 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
49000000 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
0 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
49000000 USD
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
11250000 USD
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
5000000 USD
bvs Payments To Members
PaymentsToMembers
183000 USD
bvs Payments To Members
PaymentsToMembers
14691000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-28000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
97063000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-19691000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-377000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
86000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
44078000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7958000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
86839000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
64520000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
130917000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
72478000 USD
bvs Member Distributions Incurred But Not Yet Paid
MemberDistributionsIncurredButNotYetPaid
123000 USD
bvs Member Distributions Incurred But Not Yet Paid
MemberDistributionsIncurredButNotYetPaid
607000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
612000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
580000 USD
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q2 bvs Proceeds From Governmental Assistance
ProceedsFromGovernmentalAssistance
1247000 USD
CY2020Q3 bvs Proceeds From Governmental Assistance
ProceedsFromGovernmentalAssistance
2854000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
80917000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
86839000 USD
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
50000000 USD
CY2020Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
0 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
130917000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
86839000 USD
CY2021Q4 us-gaap Escrow Deposit
EscrowDeposit
50000000 USD
CY2021Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
108504000 USD
CY2020Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
92273000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3062000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3990000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
105442000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
88283000 USD
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3019000 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5249000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3990000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4146000 USD
CY2021Q4 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
221000 USD
CY2020Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-73000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-138000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1089000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
243000 USD
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
376000 USD
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
927000 USD
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
628000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
65000 USD
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
84000 USD
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
137000 USD
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
277000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3062000 USD
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4884000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3062000 USD
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4884000 USD
CY2021Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
3381000 USD
CY2020Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
3665000 USD
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
34710000 USD
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
26323000 USD
CY2021Q4 us-gaap Inventory Gross
InventoryGross
38091000 USD
CY2020Q4 us-gaap Inventory Gross
InventoryGross
29988000 USD
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1526000 USD
CY2020Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
868000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
36565000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
29120000 USD
CY2020Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
15188000 USD
CY2021Q4 bvs Gross To Net Deductions Current
GrossToNetDeductionsCurrent
63195000 USD
CY2020Q4 bvs Gross To Net Deductions Current
GrossToNetDeductionsCurrent
43656000 USD
CY2021Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
16483000 USD
CY2021Q4 bvs Accrued Salaries And Employee Benefits Current
AccruedSalariesAndEmployeeBenefitsCurrent
6987000 USD
CY2020Q4 bvs Accrued Salaries And Employee Benefits Current
AccruedSalariesAndEmployeeBenefitsCurrent
5875000 USD
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
21000 USD
CY2020Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
2434000 USD
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
20868000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
21034000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
107554000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
88187000 USD
CY2021Q4 us-gaap Business Combination Pro Forma Information Earnings Or Loss Of Acquiree Since Acquisition Date Actual
BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual
-5396000 USD
us-gaap Business Combination Pro Forma Information Earnings Or Loss Of Acquiree Since Acquisition Date Actual
BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual
-8925000 USD
CY2021Q4 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
1575000 USD
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
8710000 USD
CY2021Q4 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0233
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
15000000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
15000000 USD
CY2021Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
889000 USD
CY2020Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1098000 USD
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
424000 USD
CY2020Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
524000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
162437000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
173378000 USD
CY2021Q1 bvs Number Of Equity Based Compensation Plans
NumberOfEquityBasedCompensationPlans
2 plan
CY2021Q1 bvs Equity Participation Right Entitled Percentage Of Distributions
EquityParticipationRightEntitledPercentageOfDistributions
0.0055
CY2021Q1 bvs Number Of Equity Based Compensation Plans
NumberOfEquityBasedCompensationPlans
2 plan
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
0 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
0 shares
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
16161000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
4621000 shares
CY2021Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
13.03
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4621000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
14.90
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
13.03
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
4000 shares
CY2021Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
14.90
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4625000 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
13.03
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
75000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
4000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
13.00
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4696000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
13.06
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y1M6D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
6061000 USD
CY2021Q4 us-gaap Profit Loss
ProfitLoss
-2269000 USD
us-gaap Profit Loss
ProfitLoss
-14498000 USD
CY2021Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1198000 USD
CY2021Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1198000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-8260000 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-1071000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6238000 USD
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41837581 shares
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41837581 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41816706 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41816706 shares
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
us-gaap Payments For Restructuring
PaymentsForRestructuring
933000 USD
CY2021Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21432749 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21280740 shares
CY2020Q4 us-gaap Restructuring Reserve
RestructuringReserve
247000 USD
us-gaap Restructuring Charges
RestructuringCharges
1798000 USD
CY2021Q4 us-gaap Restructuring Reserve
RestructuringReserve
1112000 USD
CY2021Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.280
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.045
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.062
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.024
CY2020Q3 bvs Increase In Estimated Tax Receivable
IncreaseInEstimatedTaxReceivable
7437000 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
481000 USD
CY2021Q4 us-gaap Deferred Tax Liabilities Investments
DeferredTaxLiabilitiesInvestments
45998000 USD
CY2021Q4 us-gaap Operating Lease Cost
OperatingLeaseCost
885000 USD
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
651000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
2499000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
1943000 USD
CY2021Q4 us-gaap Short Term Lease Cost
ShortTermLeaseCost
153000 USD
CY2020Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
81000 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
482000 USD
CY2020Q3 us-gaap Lease Cost
LeaseCost
732000 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
285000 USD
CY2021Q4 us-gaap Lease Cost
LeaseCost
1038000 USD
us-gaap Lease Cost
LeaseCost
2981000 USD
us-gaap Lease Cost
LeaseCost
2228000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
2598000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
1920000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16938000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14961000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2956000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1960000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
15223000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14108000 USD
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
18179000 USD
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
16068000 USD
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y2M12D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.044
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.050
bvs Stop Loss Insurance Threshold Per Member Per Year
StopLossInsuranceThresholdPerMemberPerYear
200000 USD
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
108890000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
85908000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
300484000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
222570000 USD
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
108890000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
85908000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
300484000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
222570000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3151000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8338000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
12238000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
12773000 USD

Files In Submission

Name View Source Status
0001628280-21-022681-index-headers.html Edgar Link pending
0001628280-21-022681-index.html Edgar Link pending
0001628280-21-022681.txt Edgar Link pending
0001628280-21-022681-xbrl.zip Edgar Link pending
bvs-20211002.htm Edgar Link pending
bvs-20211002.xsd Edgar Link pending
bvs-20211002_cal.xml Edgar Link unprocessable
bvs-20211002_def.xml Edgar Link unprocessable
bvs-20211002_htm.xml Edgar Link completed
bvs-20211002_lab.xml Edgar Link unprocessable
bvs-20211002_pre.xml Edgar Link unprocessable
exhibit101-q32021.htm Edgar Link pending
exhibit311-q32021.htm Edgar Link pending
exhibit312-q32021.htm Edgar Link pending
exhibit32-q32021.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending